and recommendation
Fate Therapeutics, Inc. (FATE)
Fate Therapeutics (FATE), a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.
FATE’s immuno-oncology product candidates include FATE-NK100, a natural killer (NK) cell cancer immunotherapy that consists of adaptive memory NK cells; engineered hnCD16 induced pluripotent stem cells (iPSC)-derived natural killer cell therapy candidates for hematologic/solid tumors; and engineered chimeric antigen receptor iPSC-derived T cell therapy product candidates for hematologic/solid tumors.
FATE's immuno-regulation product candidates comprise ProTmune, an investigational programmed cellular immunotherapy for use as a next-generation allogeneic hematopoietic cell transplantation cell graft; and ToleraCyte for the treatment of autoimmune and inflammatory diseases; engineered iPSC-derived CD34+ cell therapy for immune disorders.
Fate Therapeutics, Inc. has a research collaboration and license agreement with Memorial Sloan Kettering Cancer Center to develop off-the-shelf T-cell immunotherapies; a research collaboration partnership with the University of California San Diego to develop off-the-shelf chimeric antigen receptor-targeted natural killer cell cancer immunotherapies. It also has a strategic research collaboration and license agreement with Juno Therapeutics, Inc. to identify small molecule modulators that enhance the function of T cells.
Fate Therapeutics, Inc. was founded in 2007 and is headquartered in San Diego, California.
- August 1, 2014 - 9:24am | Financings
- July 30, 2014 - 7:37am | Regulatory
- July 28, 2014 - 9:00am | BOD & C-Suite Updates
- July 1, 2014 - 9:03am | Regulatory
- June 12, 2014 - 10:41am | BOD & C-Suite Updates
- May 17, 2014 - 1:31pm | Earnings, Earnings Q1
- May 17, 2014 - 1:27pm | Earnings
- April 10, 2014 - 11:25am | Regulatory
- February 23, 2014 - 3:20pm
- November 16, 2013 - 6:54pm | Research Notes
- October 7, 2013 - 9:11am | Out and About
- September 16, 2013 - 5:49pm | Research Notes
- August 14, 2013 - 2:34pm | Financings
- May 30, 2013 - 8:32pm | Out and About
- April 23, 2013 - 9:54am | Out and About
- July 12, 2012 - 12:37pm | Research Notes
- December 13, 2011 - 11:43am
- November 16, 2011 - 9:18am
- February 24, 2011 - 9:55am
- October 14, 2010 - 9:20am